Zinbryta (daclizumab beta)

pCPA File Number: 20980
Negotiation Status:
Negotiations were not pursued
Indication(s):
Multiple Sclerosis, Relapsing
Sponsor/Manufacturer:
Biogen Canada Inc.
CDA-AMC Project Number:
SR0508-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: